Cargando…
Enhancing the Activation and Releasing the Brakes: A Double Hit Strategy to Improve NK Cell Cytotoxicity Against Multiple Myeloma
Natural killer (NK) cells are innate lymphocytes with a strong antitumor ability. In tumor patients, such as multiple myeloma (MM) patients, an elevated number of NK cells after stem cell transplantation (SCT) has been reported to be correlated with a higher overall survival rate. With the aim of im...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277768/ https://www.ncbi.nlm.nih.gov/pubmed/30542346 http://dx.doi.org/10.3389/fimmu.2018.02743 |
_version_ | 1783378226040537088 |
---|---|
author | Tognarelli, Sara Wirsching, Sebastian von Metzler, Ivana Rais, Bushra Jacobs, Benedikt Serve, Hubert Bader, Peter Ullrich, Evelyn |
author_facet | Tognarelli, Sara Wirsching, Sebastian von Metzler, Ivana Rais, Bushra Jacobs, Benedikt Serve, Hubert Bader, Peter Ullrich, Evelyn |
author_sort | Tognarelli, Sara |
collection | PubMed |
description | Natural killer (NK) cells are innate lymphocytes with a strong antitumor ability. In tumor patients, such as multiple myeloma (MM) patients, an elevated number of NK cells after stem cell transplantation (SCT) has been reported to be correlated with a higher overall survival rate. With the aim of improving NK cell use for adoptive cell therapy, we also addressed the cytotoxicity of patient-derived, cytokine-stimulated NK cells against MM cells at specific time points: at diagnosis and before and after autologous stem cell transplantation. Remarkably, after cytokine stimulation, the patients' NK cells did not significantly differ from those of healthy donors. In a small cohort of MM patients, we were able to isolate autologous tumor cells, and we could demonstrate that IL-2/15 stimulated autologous NK cells were able to significantly improve their killing capacity of autologous tumor cells. With the aim to further improve the NK cell killing capacity against MM cells, we investigated the potential use of NK specific check point inhibitors with focus on NKG2A because this inhibitory NK cell receptor was upregulated following ex vivo cytokine stimulation and MM cells showed HLA-E expression that could even be increased by exposure to IFN-γ. Importantly, blocking of NKG2A resulted in a significant increase in the NK cell-mediated lysis of different MM target cells. Finally, these results let suggest that combining cytokine induced NK cell activation and the specific check point inhibition of the NKG2A-mediated pathways can be an effective strategy to optimize NK cell therapeutic approaches for treatment of multiple myeloma. |
format | Online Article Text |
id | pubmed-6277768 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-62777682018-12-12 Enhancing the Activation and Releasing the Brakes: A Double Hit Strategy to Improve NK Cell Cytotoxicity Against Multiple Myeloma Tognarelli, Sara Wirsching, Sebastian von Metzler, Ivana Rais, Bushra Jacobs, Benedikt Serve, Hubert Bader, Peter Ullrich, Evelyn Front Immunol Immunology Natural killer (NK) cells are innate lymphocytes with a strong antitumor ability. In tumor patients, such as multiple myeloma (MM) patients, an elevated number of NK cells after stem cell transplantation (SCT) has been reported to be correlated with a higher overall survival rate. With the aim of improving NK cell use for adoptive cell therapy, we also addressed the cytotoxicity of patient-derived, cytokine-stimulated NK cells against MM cells at specific time points: at diagnosis and before and after autologous stem cell transplantation. Remarkably, after cytokine stimulation, the patients' NK cells did not significantly differ from those of healthy donors. In a small cohort of MM patients, we were able to isolate autologous tumor cells, and we could demonstrate that IL-2/15 stimulated autologous NK cells were able to significantly improve their killing capacity of autologous tumor cells. With the aim to further improve the NK cell killing capacity against MM cells, we investigated the potential use of NK specific check point inhibitors with focus on NKG2A because this inhibitory NK cell receptor was upregulated following ex vivo cytokine stimulation and MM cells showed HLA-E expression that could even be increased by exposure to IFN-γ. Importantly, blocking of NKG2A resulted in a significant increase in the NK cell-mediated lysis of different MM target cells. Finally, these results let suggest that combining cytokine induced NK cell activation and the specific check point inhibition of the NKG2A-mediated pathways can be an effective strategy to optimize NK cell therapeutic approaches for treatment of multiple myeloma. Frontiers Media S.A. 2018-11-27 /pmc/articles/PMC6277768/ /pubmed/30542346 http://dx.doi.org/10.3389/fimmu.2018.02743 Text en Copyright © 2018 Tognarelli, Wirsching, von Metzler, Rais, Jacobs, Serve, Bader and Ullrich. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Tognarelli, Sara Wirsching, Sebastian von Metzler, Ivana Rais, Bushra Jacobs, Benedikt Serve, Hubert Bader, Peter Ullrich, Evelyn Enhancing the Activation and Releasing the Brakes: A Double Hit Strategy to Improve NK Cell Cytotoxicity Against Multiple Myeloma |
title | Enhancing the Activation and Releasing the Brakes: A Double Hit Strategy to Improve NK Cell Cytotoxicity Against Multiple Myeloma |
title_full | Enhancing the Activation and Releasing the Brakes: A Double Hit Strategy to Improve NK Cell Cytotoxicity Against Multiple Myeloma |
title_fullStr | Enhancing the Activation and Releasing the Brakes: A Double Hit Strategy to Improve NK Cell Cytotoxicity Against Multiple Myeloma |
title_full_unstemmed | Enhancing the Activation and Releasing the Brakes: A Double Hit Strategy to Improve NK Cell Cytotoxicity Against Multiple Myeloma |
title_short | Enhancing the Activation and Releasing the Brakes: A Double Hit Strategy to Improve NK Cell Cytotoxicity Against Multiple Myeloma |
title_sort | enhancing the activation and releasing the brakes: a double hit strategy to improve nk cell cytotoxicity against multiple myeloma |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277768/ https://www.ncbi.nlm.nih.gov/pubmed/30542346 http://dx.doi.org/10.3389/fimmu.2018.02743 |
work_keys_str_mv | AT tognarellisara enhancingtheactivationandreleasingthebrakesadoublehitstrategytoimprovenkcellcytotoxicityagainstmultiplemyeloma AT wirschingsebastian enhancingtheactivationandreleasingthebrakesadoublehitstrategytoimprovenkcellcytotoxicityagainstmultiplemyeloma AT vonmetzlerivana enhancingtheactivationandreleasingthebrakesadoublehitstrategytoimprovenkcellcytotoxicityagainstmultiplemyeloma AT raisbushra enhancingtheactivationandreleasingthebrakesadoublehitstrategytoimprovenkcellcytotoxicityagainstmultiplemyeloma AT jacobsbenedikt enhancingtheactivationandreleasingthebrakesadoublehitstrategytoimprovenkcellcytotoxicityagainstmultiplemyeloma AT servehubert enhancingtheactivationandreleasingthebrakesadoublehitstrategytoimprovenkcellcytotoxicityagainstmultiplemyeloma AT baderpeter enhancingtheactivationandreleasingthebrakesadoublehitstrategytoimprovenkcellcytotoxicityagainstmultiplemyeloma AT ullrichevelyn enhancingtheactivationandreleasingthebrakesadoublehitstrategytoimprovenkcellcytotoxicityagainstmultiplemyeloma |